Literature DB >> 18641548

Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose.

Michael Bodmer1, Thilo Burkard, Oliver Kummer, Ralf Beyrau, Stephan Krähenbühl, Manuel Haschke.   

Abstract

We present a case of massive overdose with the atypical antipsychotic quetiapine in a 34-year-old woman (body weight 65 kg). At admission, approximately 2 to 4 hours after ingestion of approximately 24 g of quetiapine, the patient was comatose (Glasgow Coma Scale score 5), requiring orotracheal intubation and transfer to the intensive care unit. Because of myoclonic jerks and generalized seizures, benzodiazepines were administered. In addition to transient mild hypotension after intubation, the main cardiovascular manifestation was sinus tachycardia. The QT interval was normal, and the QTc interval (Bazett's correction) was maximally prolonged to 620 ms. However, no malignant arrhythmias were observed. The patient recovered within 2 days but remained agitated and aggressive, for which she was transferred to the psychiatric clinic. The pharmacokinetics of quetiapine in such a large overdose could not be described by simple first-order kinetics. The initially observed rapid decline of the plasma concentrations of quetiapine could be simulated by first-order kinetics (half life = 4.1 hr) and can most probably be explained by rapid distribution into tissues. The final elimination of the drug from the body occurred after approximately 34 hours at much slower rate, most probably reflecting redistribution from tissues into blood and consecutive hepatic clearance of the drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641548     DOI: 10.1097/FTD.0b013e31817fd5ed

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

Review 1.  Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.

Authors:  Michael Levine; Anne-Michelle Ruha
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa).

Authors:  Friedrich G Kapp; Hans H Maurer; Volker Auwärter; Martin Winkelmann; Maren Hermanns-Clausen
Journal:  J Med Toxicol       Date:  2011-09

Review 3.  Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Authors:  Mehrul Hasnain; W Victor R Vieweg; Robert H Howland; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Jules C Hancox; Geneviève C Digby; Adrian Baranchuk; Anand Deshmukh; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2014-06

Review 4.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

5.  Serum fluoxetine and norfluoxetine levels support the safety of fluoxetine in overdose.

Authors:  Stephanie Pope; Solomon G Zaraa
Journal:  Ann Gen Psychiatry       Date:  2016-11-09       Impact factor: 3.455

6.  Delayed-Onset Seizure in a Mild Quetiapine Overdose: Report of a Case and Review of the Literature.

Authors:  Jason A Chen; Katherine M Unverferth; Erick H Cheung
Journal:  Case Rep Psychiatry       Date:  2018-05-15

7.  Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine.

Authors:  Motohiro Okada; Kouji Fukuyama; Eishi Motomura
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.